Skip to main content
SpringerLink
Log in

Generics vs brand name drug pricing: pros and cons debated

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. AARP.Looking to Save on Drugs? Go Generic. Media Release: 16 Apr 2009. Available from: URL: http://www.aarp.org

  2. PhRMA.PhRMA Statement on AARP Report. Media Release: 16 Apr 2009. Available from: URL: http://www.phrma.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Generics vs brand name drug pricing: pros and cons debated. Pharmacoecon. Outcomes News 577, 10 (2009). https://doi.org/10.2165/00151234-200905770-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905770-00023

Keywords

Search

Navigation